Summary.A set of specific glycoproteins, the colony-stimulating factors, has been identified as regulating granulocyte and macrophage production and function. These colony-stimulating factors have now been purified and mass produced by recombinant technology. These versatile regulators are capable of providing the body both with an ultrarapid and sustained system for responding to infections. The granulocytes, macrophages and eosinophils involved in these responses appear likely to be key cell populations ensuring adequate resistance to acute infections and the colony-stimulating factors may prove to be valuable agents in the clinic for increasing resistance to life-threatening infections particularly in immunologically compromised patients.The science of immunology arose out of attempts to understand and improve the manner in which the body responds to and overcomes infections. It was evident from the outset that resistance to infections involved the combined functional activity of a variety of white cells and a set of vaguely characterized reticuloendothelial cells. Granulocytes, macrophages and endothelial cells occupied an important position in early studies on resistance but, for the past forty years, immunology has been dominated by considerations of the mechanism of generation of specific antibodies and the functional activity of T and B lymphocytes. While in no way disputing the importance of antibodies and lymphocytes, particularly in suppressing second infections by the same organism, this preoccupation with lymphocytes led to an unfortunate down-modulation of work on the other cells involved in resistance. Watching the evolution of work on lymphocyte biology as an interested bystander, it seemed to me that the relatively slow proliferative and functional responses of lymphocytes were unlikely to provide the rapid response systems required for the initial control of infections by highly pathogenic organisms and that lymphocyte responses were relatively inefficient in handling certain types of infection, e.g. by fungi. In considering these shortcomings, it seemed more likely that effective early resistance relied heavily on the number, localization and functional activity of granulocytes and macrophages. However, in the absence of any sophisticated methods for influencing granulocyte-macrophage function, these were no more than idle convictions.Work in the past twenty years, and particularly in the last few years, has greatly increased our understanding of the molecular control of granulocyte-macrophage populations. This can best be exemplified by noting that clinical trials will be undertaken in the coming year using recombinant granulocytemacrophage colony-stimulating factors to increase the production and functional activity of granulocytes and macrophages in patients with depressed haemopoiesis and infections.It is useful therefore on this occasion to review briefly the present state of knowledge of the colony-stimulating factors and their actions in vivo in the context of the role these factors may...